Connection
Maryam Asgari to Antibodies, Monoclonal
This is a "connection" page, showing publications Maryam Asgari has written about Antibodies, Monoclonal.
|
|
Connection Strength |
|
 |
|
 |
|
0.161 |
|
|
|
-
Asgari MM, Ray GT, Geier JL, Quesenberry CP. Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population. J Am Acad Dermatol. 2017 Apr; 76(4):632-638.
Score: 0.089
-
Wu JJ, Liu L, Asgari MM, Curtis JR, Harrold L, Salman C, Herrinton LJ. Initiation of TNF inhibitor therapy and change in physiologic measures in psoriasis. J Eur Acad Dermatol Venereol. 2014 Oct; 28(10):1380-7.
Score: 0.071